Andrew J. Sauer, MD’s Post

Friday morning session at #ESC2024 Everything you wanted to learn about semaglutide, focused on obesity and heart failure, 😞 inflammation, atrial fibrillation, echo markers, CKD and more! Anticipate a flurry of papers to come out simultaneously as we kick off the Congress! Mikhail Kosiborod Saint Luke's Mid America Heart Institute Saint Luke's Health System Melissa Magwire RN MSN CDCES Cardiometabolic Center Alliance

13 Important HF STATS: See the link to the HFSA website at the end. 1. Approximately 6.7 million Americans over 20 years of age have heart failure (HF), and the prevalence is expected to rise to 8.5 million Americans by 2030. 2. The lifetime risk of HF has increased to 24%; approximately 1 in 4 persons will develop HF in their lifetime. 3. Approximately 33% of the United States (US) adult population is at risk for HF (Stage A HF), and 24-34% have pre-HF (Stage B HF). 4. The risk of developing HF in individuals with obesity and hypertension has increased. 5. The incidence and prevalence of HF are higher among Black individuals compared with other racial and ethnic groups. 6. The prevalence of HF has increased among Black and Hispanic individuals over time. 7. HF mortality rates have been increasing since 2012. 8. Black, American Indian, and Alaska Native individuals have the highest all-cause age-adjusted HF mortality rates compared with other racial and ethnic groups. 9. From 2010 to 2020, HF mortality rates have increased for Black women and men at a rate higher than any other racial or ethnic groups, particularly for individuals below the age of 65. 10. A greater relative annual increase in HF-related mortality rates has been noted for younger (35-64 years) compared with older (65-84 years) adults. 11. Rural areas demonstrate higher HF mortality rates for both younger and older age groups compared with urban areas. 12. Rates of HF hospitalizations have increased from 2014 to 2017. This increase was consistent between age groups and sexes, with the highest rates being among Black patients. 13. Disparities in social determinants of health and health inequities are important HF risk factors and result in increased mortality and other adverse outcomes in individuals at risk for HF or with HF. https://hfstats.org/

Artificial intelligence. Cardiovascular medicine. An update. EHJ. https://lnkd.in/gkDuBrED

🆕 #JACC state-of-the-art review highlights a shift toward a more tailored approach in the management of stable angina by performing a precise endotype diagnosis in patients with INOCA. https://lnkd.in/gy3ey8BC

Patient in clinic: How it started: 35F, NICM, genetic testing neg Original BMI 40+ LVEDD 6.5 cm, LVEF 20%, LBBB How it’s going: 1. ARNi, BB, MRA, SGLT2i 2. CRT for LBBB after partial recovery on GDMT 3. GLP1 She’s down 130 lbs LV has normalized in size/fxn “Just Do It.”